6

Click here to load reader

The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

Embed Size (px)

DESCRIPTION

"The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III", is part three of BioInformatics LLC’s on-going analysis of the market for antibodies. One thousand scientists completed a 35-question survey fielded between April 28 and May 6, 2009 — making this the most current information available pertaining to the antibody market today. This report is designed to enable suppliers to be responsive to scientists’ expectations – and preferences – as regards to selection, availability, delivery time, pricing and supplier/brand. The findings in this study will offer insight as to a supplier’s competitive standing, and provide direction as to how fine-tune product offerings and move into the position of scientists’ supplier of choice.

Citation preview

Page 1: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 1 of 6

©2009 BioInformatics, LLC

EXECUTIVE SUMMARY

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III

REPORT #09-004May 2009

Print: $3,200 $2,700Electronic (.pdf): $5,200 $4,500

OverviewSuppliers of antibodies continue to seek ways to differentiate their offerings from that of the competition. Responding to the specific—and unique— requirements of scientists using antibodies for research entails an in-depth knowledge of scientists’ expectations and preferences as regards to selection, availability, delivery time, pricing and supplier/brand. The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III was designed to provide insight as to what types of antibody-based techniques scientists are using in their research, and specifically, what attributes of the customer’s experience with an antibody product line most influence purchasing behaviors in the lab.

Readily quantifiable, this study reveals actual purchases—product type, packaging, amount spent and preferred supplier—over the past 12 months. Respondents also project future expenditures for the next 12 months.

The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III will help suppliers better understand how antibodies are used and how demand is impacted by scientific application. In addition, segmentation analysis and trend comparisons will allow suppliers to adapt to preferences by type of customer, and to modify product offerings to accurately reflect changes in the antibodies market. This report can be used to assess a supplier’s competitive position and to validate internal market share/size calculations. This information will also help suppliers better understand their strengths and weaknesses as compared to their competitors and gauge their brand’s overall performance in the antibody market.From the perspective of researchers who use commercial,

pre-made catalog antibodies, the primary objectives of this report are as follows:

• Reveal market specific differences in usage of antibody-based techniques by segmentation analysis

• Determine market share by usage rates for different market segments and geographic regions

• Assess market growth potential

• Identify leading suppliers of commercial, pre-made catalog antibodies and those suppliers that differentiate themselves through product quality and customer service

• Highlight market factor(s) that influence a customer’s decision to purchase one brand of pre-made catalog antibodies over another

• Provide insights into which product attributes contribute to customer satisfaction and customer dissatisfaction

• Measure customer loyalty via respondents’ willingness to promote a particular brand

• Calculate a customer value scores for suppliers

• Evaluate brand health of the top suppliers based upon key performance metrics related to product promotion, product attractiveness, product price, product placement and supplier customer service and technical support

Report Objectives

This pre-publication discount price is only available until May 29, 2009!

2111 Wilson Blvd Suite 250

Arlington, VA 22201www.gene2drug.com

703.778.3081 (fax)

BioInformaticsmarket insights from gene to drug

What commercial retailer do your customers think of when they purchase antibodies from your company?

Find out on Twitter…http://twitter.com/ScienceAdvBoard

Page 2: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 2 of 6

©2009 BioInformatics, LLC

1,000 scientists completed a 35-question survey conducted by BioInformatics, LLC (Arlington, Virginia, USA) between April 28 and May 6, 2009 — making this the most current information available on the antibody market.

The electronic questionnaire was fielded to registered members of The Science Advisory Board. BioInformatics sponsors The Science Advisory Board, an online community of more than 43,000 scientists, physicians and healthcare professionals from around the world. The Science Advisory Board is divided into two panels (Research and Clinical) and “convenes” regularly via the World Wide Web (www.scienceboard.net) to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. These experts—representing all aspects of the life sciences and medicine—have agreed to make themselves available to participate in our online research activities. The Science Advisory Board members who participated in this study were drawn from the Board’s Research Panel.

Customers were asked to indicate the supplier providing the best overall experience in terms of product quality and service for pre-made catalog antibodies. These scientists were then asked to rate their best supplier on key measures of performance and allows for side-by-side comparisons of the market’s leading companies.

Methodology Sample Contents

Demographics

52%

17%

16%

8%

2%

2%

3%

0% 10% 20% 30% 40% 50% 60%

Academic

Hospital or University Medical

Center

Pharmaceutical/Biotechnology

Government

Contract Research

Private Research

Other

62%

26%

10%

0% 10% 20% 30% 40% 50% 60% 70%

North America

Europe

Asia/Pacific

Qualified Respondents from Key Market Segments & Regions

Pre-made

catalog

antibodies

72.0%

Custom

antibodies

made by a

commercial

supplier

11.0%

Custom

antibodies

made in-house

8.9%

Antibodies

from

colleagues

8.1%

What percent of the antibodies that you have used over the last 12 months were obtained from each of the following sources? (total should equal 100%)

Contact us at 703.778.3080 x13 to review the study questionnaire

Page 3: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 3 of 6

©2009 BioInformatics, LLC

Report HighlightsThe Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. IIIREPORT #09-004

Section 1. Analysis and Interpretation of Survey Results

• Executive Overview

• Study Objectives

• Antibody Sources

• Antibody Usage

• Antibody Suppliers

• Market Share Estimations

• Market Growth Potential

• Purchasing Influences

• Customer Satisfaction with Antibody Product Features

• Customer Loyalty

• Customer Value Assessment

• Brand Share Index

• Conclusion

Section 2. Study Methodology and Demographics• Methodology

• Demographics

• Questionnaire

Section 3. Presentation of Survey DataAntibody Uses and Applications

• Antibody-based techniques used in research

• Sources of antibodies

• Number of primary & secondary antibodies used in the past 12 months

• Protein families used in antibody research

Antibody Ordering Information• Number of primary and secondary pre-made catalog

antibodies from commercial suppliers used in the past 12 months

• Use and types of conjugated secondary antibodies

• Unit sizes typically ordered for pre-made catalog antibodies

• Number of vials or tubes of pre-made catalog antibodies typically ordered at a time

• Number of orders for pre-made catalog antibodies placed in the past 12 months

• Expected number of vials or tubes of pre-made catalog antibodies from commercial suppliers over the next 12 months

• Average amount of money spent per order of pre-made catalog antibodies

• Date of last order for pre-made catalog antibodies placed

Commercial Suppliers• Suppliers used for orders in the past 12 months

• Percentage of budget for pre-made catalog antibodies spent on each brand

Satisfaction with Commercial Antibody Suppliers• Satisfaction with product features

• Overall satisfaction with value for money for pre-made catalog antibodies from commercial suppliers

• Supplier who has provided the best overall experience in terms of product quality and customer service

Purchasing Influences for Commercial Antibody Suppliers

• Factors influencing decision to purchase from best supplier

• Relative influence of factors in decision to purchase from best supplier

• Likelihood of purchasing from best supplier again in the next 12 months

• Likelihood of recommending best supplier to a colleague

• Number of orders for pre-made catalog antibodies placed with best supplier in the past 12 months

• Length of time purchasing antibodies from best supplier

Brand Experience with Commercial Antibody Suppliers

• Overall rating of experience in obtaining pre-made catalog antibodies from best supplier

• Familiarity with pre-made catalog antibodies available from best supplier

• Acceptability of prices of pre-made catalog antibodies from best supplier

• Ease of obtaining pre-made catalog antibodies from best supplier

• Helpfulness of customer service from best supplier

• Helpfulness of technical support from best supplier

• Attribute most closely identified with best supplier

Demographics

Leading Antibody Supplier Profiles

Section 4. Appendices• Insights and Perspectives

• Cross-Tabulations of Survey Data

Page 4: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 4 of 6

©2009 BioInformatics, LLC

Other Recent Publications*

Life Science Marketing

#09-002 Capitalizing on New Opportunities for Stem Cell Products April 2009 263 Pages

#09-001 Prospering in a Down Market: Strategies for Life Science Suppliers March 2009 159 Pages

#08-047 The Brave New World of Scientific Publishing November 2008 154 Pages

#08-019 Enabling Discovery: The 2008 Life Science Industry AwardsTM June 2008 101 Pages

#08-008 Instrumentation Service Contracts: Opportunities for Differentiation July 2008 136 Pages

#08-007 Protein Research: Strategies for Marketing to Chemists and Biologists September 2008 123 Pages

#08-006 Understanding Switching Dynamics: Maximizing Customer Retention in the Life Science March 2008 173 Pages

#08-004 Life Science Product Catalogs: Techniques to Increase Sales March 2008 92 Pages

#08-003 Conference & Exhibit Strategies in the Life Sciences: What’s Working Now February 2008 135 Pages

#08-002 Advertising to Life Scientists: Resolving the Print vs. Online Dilemma February 2008 105 Pages

#08-001 Marketing to Life Scientists: Capturing Customers’ Attention in Applied Markets January 2008 156 Pages

*See Web site www.gene2drug.com for a complete listing.

Sources of Independent, Unbiased ResearchUnlike reports from other firms that are based on an analyst’s subjective summary of information from publicly available sources, our reports are based on the results of detailed surveys of hundreds—even thousands—of scientific and medical professionals who buy your products.

Developed by a Team of ExpertsOur questionnaires are developed by a multi-disciplinary team of scientists, industry veterans and market research experts with years of experience. These professionals understand that survey questions need to be asked in a way that ensures the answers will directly address the business challenges you face. Once the survey data is collected, this same team creates a unique report that presents the reader with a thorough understanding of the topic and the scientific and business implications of the results based on sophisticated statistical analytics.

Custom Analysis & Research AvailableIf you’d like to delve deeper into the data from a study, we can always perform custom cross-tabulations or other analysis on your behalf. We can even pose follow-up questions to respondents who answered in a particular way or conduct a custom study to extend your knowledge.

Carefully Selected Survey ParticipantsWhen others promote results from their online surveys, they fail to mention the uncontrolled nature of their broadcast email invitations. To provide you with the most valid and accurate results possible, the respondents to our surveys are members of our unique online panel—The Science Advisory Board—which consists of more than 43,000 verified life science and biomedical professionals who have agreed to take part in our surveys, focus groups and other market research activities. These respondents are carefully selected based on their professional qualifications, market segments and geographic regions—we can even select them based on the products they use and their preferred suppliers.

Complimentary Consulting ProvidedWith your purchase, we offer one free hour of consultation with our talented team of scientific and business analysts who created the report. During this consultation, we can answer any questions you may have about the survey results and what we believe to be the significant trends affecting the market.

Why choose our reports?

Invest in the most direct source of information from the scientists who buy your products, and the expert team that has been monitoring your clients since 1994.

Page 5: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 5 of 6

©2009 BioInformatics, LLC

About BioInformatics, LLC Since our inception in 1994, BioInformatics has provided critical market intelligence to leading companies serving the life science, medical device and pharmaceutical industries. We support clients across the entire market spectrum—from scientific research to diagnostics and therapeutics—providing high-level management with market insights from gene to drug.

Our multi-disciplinary team of scientific experts and business analysts creates value for our clients by combining extensive industry knowledge and experience. We offer a variety of products and services that enable executives to see themselves, their market and their competitors through the eyes of the most important information source of all—customers. We can precisely meet the needs of our clients through the most appropriate mix of research methodologies, including:

• Online Surveys• Online Focus Groups• Mail Surveys• Telephone Interviews

Our strength lies in our ability to integrate our understanding of science and medicine with cutting-edge market research techniques. As one of the first firms to recognize how the World Wide Web has transformed market research, BioInformatics formed The Science Advisory Board. Launched in 1997, this global community currently consists of more than 43,000 life science researchers, physicians and biomedical professionals who convene regularly via the Web to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. Clients tap into this panel of experts and receive answers to their critical marketing questions in days, rather than weeks. In addition to providing real-time insights into the perceptions of the market, posing questions to The Science Advisory Board offers substantial cost savings over gathering information via traditional market research techniques.

BioInformatics offers both published reports and custom research services. Published reports allow marketing professionals to share in the results of broad-based market studies that provide access to high quality research at an affordable price. Our custom research is tailored to the specific needs of the company’s executive management. For more information about BioInformatics’ product and service offerings, please visit our Web site at www.gene2drug.com, call 703.778.3080 or email [email protected].

Biotechnology/Life Science454AbCamAccelrysAffymetrixAgencourt BioscienceAgilent TechnologiesAmerican Type Culture

CollectionAnachemAntibodies By DesignApple ComputerApplied BiosystemsApplied PrecisionAxxoraBD BiosciencesBeckman CoulterBiacoreBio-Rad LaboratoriesBioneerBiotageBioTroveBlue Heron BiotechnologyCaliper TechnologiesCallida GenomicsCambrex Bio ScienceCarl ZeissCell Signaling TechnologyCellianceCharles River LaboratoriesChromaVision Medical

SystemsCipher SystemsClontech LaboratoriesCorningDAKODNAStarDow CorningDynal BiotecheBIOINFORMATICSEdge BiosystemsEksigent TechnologiesEM Separations TechnologyEMD BiosciencesEntelechonEpigenomicsEpitomicsEpoch Biosciences

EppendorfEurogentecExpression PathologyFermentasFluidigmGE HealthcareGen-ProbeGene CodesGene LogicGene Therapy SystemsGentra SystemsGenVault CorporationGenzymeGuava TechnologiesHelicos BioSciencesHewlett-PackardHigh Throughput GenomicsHitachi InstrumentsHybrigenicsHyseqIBM Life SciencesIlluminaImmunotechInforMaxIntegrated DNA TechnologiesInvitrogenJRH BiosciencesKirkegaard & Perry

LaboratoriesKodak Scientific ImagingLeica MicrosystemsLI-CORLION bioscienceLonzaLuminexMDS SciexMettler-Toledo AutoChemMilliporeMiraiBioMolecular DevicesMWG BiotechNew England BiolabsNuGEN TechnologiesOvid TechnologiesPall Life SciencesPercival ScientificPerkinElmer Life SciencesPhotometrics

Plexagen DiagnosticsPost Genome InstitutePromegaProtein ForestProteome SystemsQbiogeneQIAGENR & D SystemsRibomed BiotechnologiesRosetta BiosoftwareSachemSarstedtSandia National LaboratoriesSAS InstituteSchott NexterionSequenomSerologicalsSerotecSigma-AldrichSolexaSomaLogicSource Precision MedicineStratagene Stressgen BiotechnologiesTakara Mirus BioTecanThe Jackson LaboratoryThermo Fisher ScientificThomas ScientificTocris CooksonTransgenomicUVPVarianVWR InternationalVysisWatersWhatman

Medical DiagnosticsApplied ImagingCiba Corning DiagnosticsDade BehringDiagnostic Products Diametrics MedicalHewlett-Packard Medical

ProductsLifeScanMallinckrodt

Ortho-Clinical DiagnosticsRadiometer AmericaTektronix

PharmaceuticalsAbbott LaboratoriesAmgenAstraZenecaAventisBaxter HealthcareBayer Boehringer Ingelheim

PharmaceuticalsCardinal HealthCentocorHoechst Marion RousselICN PharmaceuticalsJanssen PharmaceuticaMerckNovartis PharmaceuticalsNovo Nordisk

PharmaceuticalsPfizerSchering-Plough

Professional Services & FinanceAdjuvant PartnersAdventus ResearchAgency.comAnvil GroupAtlas VentureBattelle Memorial InstituteBioOnlineCitadel Investment GroupDoran Media ServicesFidelity Management and

ResearchFoley & LardnerGerson Lehrman GroupHSBC SecuritiesInfotrieveInnovative Marketing GroupMcKinsey & Co.Nathan AssociatesNational Research Council of

CanadaNovintel

Phillip Johnson & AssociatesPA ConsultingPerry BallardPiper JaffrayRuder FinnScherago InternationalSelect Equity GroupStephan & BradyThe Strategy WorksUBS Warburg

Publishers & Associations Academic PressAmerican Academy of

PediatricsAAAS/ScienceAmerican Medical AssociationAmerican Society for Cell

BiologyAmerican Society for

MicrobiologyAmerican Society of Human

GeneticsBioTechniques/Eaton

PublishingBlackwell PublishingCold Spring Harbor

Laboratory PressElsevier Federation of Amer. Societies

for Experimental BiologyHarvard University Medical

SchoolJohn Wiley & SonsMary Ann Liebert PublishersNature Publishing GroupNew England Journal of

MedicineSociety for NeuroscienceSpringer-VerlagStanford University High Wire

PressThomson ISIWolters Kluwer

Our Valued Clients

Page 6: The Market for Antibodies: Keys to Success for Commercial Suppliers Vol. 3

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Executive Summary Page 6 of 6

©2009 BioInformatics, LLC

REPORT #09-004 The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III

PRE-PUBLICATION DISCOUNT PRICES are only available until May 29, 2009!Print Copy—$3,200 Now $2,700!Electronic Copy (includes one print copy)—$5,200 Now $4,500!

I wish to order the following format of REPORT #09-004, The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III Discount Price

o Print Copy $2,700 $________

o Electronic Copy (.pdf, includes print copy) $4,500 $________

o Add Data Set Excel or SPSS (circle one) +$1,200 +$________

Additional print copies _____ x $300 each +$________

Promo Code ___________ –$________ Shipping & Handling (Add $15 for U.S., $50 for Int’l) +$________

Total $________

Name

Title

Organization

Street Address

City, State/Province, Postal Code

Country

Phone Fax

Email

o Check Enclosed (Payable to BioInformatics, LLC)

o Purchase Order # ________________________________________

o Am Ex o MasterCard o Visa o Diner’s Card o Discover

/Credit Card # Exp Date (MM/YY)

Name on card _____________________________________________

Order Authorized By:

__________________________________________________________ Signature Date

To place an order, fill out this form and mail it to BioInformatics, LLC or fax it to 703.778.3081. Alternatively, you may submit your order by emailing [email protected], calling 703.778.3080 x13 or visiting www.gene2drug.com/order/202/.

Payment must be made within 30 days and in U.S. dollars. BioInformatics’ Federal Tax ID #: 54-2001907.

Credit CardYou may charge your order to American Express, MasterCard, Visa, Diner’s Card or Discover. Please include your credit card account number, expiration date and signature.

Wire TransfersWire transfers should be sent to: SunTrust Bank, 2121 15th Street, Arlington, VA 22201, SWIFT #SNTRUS3A, ABA #071000104, Account #702260169.

Electronic CopyThis format allows an unlimited number of users within your company to access the report regardless of geographic location. You may place the electronic copy (PDF) on your secure, corporate intranet or share it with co-workers via email. In addition to providing greater accessibility, the electronic copy allows you to easily navigate the document with the help of bookmarks, quickly search key words or phrases and print out any page. One print copy of the report is also provided at no additional cost.

Data SetTo accommodate your unique needs, the raw data is also available. With the data, you can analyze respondents’ answer choices in any way needed, including cross-tabulations, correlations, etc. The data set is offered in two formats: SPSS® Base or Microsoft® Excel, and may only be purchased in conjunction with the company-wide electronic copy of the report.

Ordering Information

BioInformatics, LLC 2111 Wilson Blvd., Suite 250 Arlington, VA 22201

Web: www.gene2drug.com • Phone: 703.778.3080 x13 • Fax: 703.778.3081 • Email: [email protected]

BioInformaticsmarket insights from gene to drug